Molecule Details
| InChIKey | DZCWNAMURCVSNJ-UHFFFAOYSA-N |
|---|---|
| Compound Name | 1-(4-amino-1,2,5-oxadiazol-3-yl)-5-thiophen-2-yl-N-(thiophen-2-ylmethylideneamino)triazole-4-carboxamide |
| Canonical SMILES | Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1cccs1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 4 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 6.85 |
| Source | ChEMBL |
2D Structure
Activity Profile
Target Activities (4)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| P49840 | GSK3A | Homo sapiens | Human | PF00069 | 7.3 | Ki | ChEMBL |
| Q5VT25 | CDC42BPA | Homo sapiens | Human | PF00130 PF00780 PF08826 PF15796 PF25346 PF00069 PF00433 | 7.2 | Ki | ChEMBL |
| P49841 | GSK3B | Homo sapiens | Human | PF00069 | 6.8 | Ki | ChEMBL |
| Q13627 | DYRK1A | Homo sapiens | Human | PF00069 | 6.1 | Ki | ChEMBL |